New Measures Increase Productivity at INPI
By Julian Cornelius Earlier this month, the Brazilian Patent Office (INPI) released its latest report regarding activities in 2018. The presented figures provide grounds for cautious optimism. In comparison to last year, there is a significant increase in productivity in the area of patents, both in terms of reducing the numbers of pending applications and […]
New Study on the Categorization of Brazilian Biotechnology Patent Documents
By Karina Daiha and Julian Cornelius In November, the Brazilian Patent Office (INPI) released a new study on the categorization of biotechnology patent documents based on international patent classification, also presenting an analysis of the patent filing in this sector in Brazil between 2012 and 2016. The study compared concepts of biotechnology based on the […]
Update on Patent Protection for Business Methods in Brazil
By Andre Venturini The current position in Brazil is that any commercial, financial and accounting principle or scheme cannot receive patent protection under article 10 of the Industrial Property Law (LPI). Eligibility of such subject matter, collectively known as “business methods”, is a controversial topic, which was the subject of recent reform in US legislation. […]
Hepatitis C: Divergent Public Opinion
Hepatitis C: Divergent Public Opinion and Industrial Property Law in Brazil By Karina Daiha and Patrik Gandara On September 18, 2018, the National Institute of Industrial Property (INPI) published its approval (9.1) of the patent application for the active pharmaceutical ingredient Sofosbuvir. The ingredient is used in the production of the drug Sovaldi® (Gilead) […]
